In addition, Cai et al. (41) demonstrated that PCP suppresses the production of inflammatory mediators by downregulating protein expression in the TLR4/NF-κB pathway, thereby reducing the generation and infiltration of inflammatory cells and subsequently alleviating inflammatory damage in lung tissue. The gene discussed is NFKB1; the disease is pneumocystosis.